Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical ...

Charlie Morgan was diagnosed with chronic myeloid leukaemia, a rare cancer in his age group ...

The US stock market has endured a turbulent start to the year, with global crude oil prices spiking up and inflation surging ...

The US Food and Drug Administration (FDA) has accepted Nilopki® as the proprietary name for Xspray Pharma's drug candidate XS003 (nilotinib). Nilopki is an improved, amorphous formulation of nilotinib ...

The research on bone-marrow transplantation mirrors the arc of many medical advancements. I was one of the early ...

First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose and ...

Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year ...

A recent study published in Otolaryngology–Head and Neck Surgery finds that two common and treatable causes of conductive ...

Matthew Powell, MD, discusses long-term overall survival results with dostarlimab plus chemo in dMMR endometrial cancer ...

Acute myeloid leukemia (AML) has a poor prognosis, especially in elderly and relapsed/refractory patients, with 5‑year survival below 30% ...

CVS Caremark’s preferred-formulary shift from tirzepatide to semaglutide produced a 17-fold jump in tirzepatide switching ...